Benign breast disease - The risks of communicating risk

New England Journal of Medicine

Volumn 353, Issue 3, 2005, Pages 297-299

  Elmore, Joann G ^a   Gigerenzer, Gerd ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BREAST CANCER; BREAST DISEASE; BREAST EXAMINATION; BREAST HYPERPLASIA; BREAST LESION; CANCER RISK; CANCER SCREENING; EDITORIAL; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; BREAST TUMOR; FEMALE; INTERPERSONAL COMMUNICATION; METHODOLOGY; NOTE; RISK;

BREAST DISEASES; BREAST NEOPLASMS; COMMUNICATION; FEMALE; HUMANS; RISK; RISK ASSESSMENT;

EID: 22344441474     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe058111     Document Type: Editorial

References (15)

1. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37.
2. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000;342:564-71.
3. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003;348:1672-80.
4. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-96.
5. Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 2003;27:836-41.
6. Wells WA, Carney PA, Eliassen MS, Tostenson AN, Greenberg ER. A statewide study of diagnostic agreement in breast pathology. J Natl Cancer Inst 1998;90:142-5.
7. Gigerenzer G. Calculated risks: how to know when numbers deceive you. New York: Simon & Schuster, 2002.
8. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ 2002;324:827-30.
9. Paling J. Strategies to help patients understand risks. BMJ 2003;327:745-8.
10. Alaszewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively? BMJ 2003;327:728-31.
11. Jekel J, Elmore J, Katz D. Epidemiology, biostatistics and preventive medicine. Philadelphia: Harcourt Health Sciences, 2001.
12. National Cancer Institute. Models for prediction of breast cancer risk: Gail model. (Accessed June 30, 2005, at http://www.cancer. gov/bcrisktool/.)
13. Preventive Services Task Force. Chemoprevention of breast cancer: recommendations and rationale. Ann Intern Med 2002;137:56-8.
14. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;293:1245-56.
15. Deyo RA, Patrick DL. Hope or hype: the obsession with medical advances and the high cost of false promises. New York: AMACOM, 2005:335.